TapewireFind a company

person · Reporting owner

Gayle Helene D

Disclosed activity across 5 companies

Tapewire entity
11343
SEC CIK
0001487047

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
COCA COLA COKO · Entity 2806DirectorApril 01, 2024April 03, 2024
COLGATE PALMOLIVE COCL · Entity 2972DirectorApril 01, 2021April 05, 2021
GoHealth, Inc.GOCO · Entity 22896DirectorSeptember 14, 2021September 16, 2021
Organon & Co.OGN · Entity 4115DirectorJune 12, 2026June 15, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

COCA COLA CO

Report date April 01, 2024 · Filed April 03, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Share UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct61,143.8912 Reported balance After 2024-04-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2024-04-01 · Grant · Acquired 3,280.3018 · Balance 61,143.8912

F1: Each phantom share unit is economically equivalent to one share of Common Stock.

F2: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2024 compensation, which may include voluntary deferred compensation.

F3: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4: This number includes phantom share units accrued through April 1, 2024 under the Directors' Plan as a result of crediting phantom dividends.

Common Stock, $.25 Par ValueSEC Table I · non-derivativeDirect3,000 Reported balance Holding disclosure · report date 2024-04-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 3,000

Filing footnotes · ownership attribution and instrument terms

F1: Each phantom share unit is economically equivalent to one share of Common Stock.

F2: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2024 compensation, which may include voluntary deferred compensation.

F3: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4: This number includes phantom share units accrued through April 1, 2024 under the Directors' Plan as a result of crediting phantom dividends.

COLGATE PALMOLIVE CO

Report date April 01, 2021 · Filed April 05, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect21,063 Reported balance After 2021-04-01 transaction · row 1
1 source row

Row 1 · 2021-04-01 · Grant · Acquired 228 · Balance 21,063

F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Common StockSEC Table I · non-derivativeIndirectBy Trust19,689 Reported balance Holding disclosure · report date 2021-04-01 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 19,689

Filing footnotes · ownership attribution and instrument terms

F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

GoHealth, Inc.

Report date September 14, 2021 · Filed September 16, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect12,831 Reported balance After 2021-09-14 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2021-09-14 · Grant · Acquired 5,688 · Balance 12,831

F1: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer.

F2: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer.

F2: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

Organon & Co.

Report date June 12, 2026 · Filed June 15, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect81,141.134 Reported balance After 2026-06-12 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-12 · Grant · Acquired 17,857.143 · Balance 81,141.134

F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Palo Alto Networks Inc

Report date December 12, 2024 · Filed December 17, 2024

Section 16 reporting ended · disclosed 2024-12-17. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 12, 2026 Filed Jun 15, 2026 20:34 UTC Organon & Co. OGN · Entity 4115 GrantPhantom Stock · Derivative 17,857.143 $13.44 $240,000.00
Disclosure

SEC source: 0001628280-26-043228 · wk-form4_1781555680.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,141.134

Underlying: Common Stock · 17,857.143 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 21:22 UTC Organon & Co. OGN · Entity 4115 GrantPhantom Stock · Derivative 23,904.382 $10.04 $240,000.00
Disclosure

SEC source: 0001821825-25-000047 · wk-form4_1750108969.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,702.656

Underlying: Common Stock · 23,904.382 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3 · balance_after: Holdings include phantom stock units acquired in dividend reinvestment transactions on June 13, 2024, September 12, 2024, December 12, 2024, March 13, 2025 and June 12, 2025.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:48 UTC Palo Alto Networks Inc PANW · Entity 1811 GrantCommon Stock 915 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-135529 · ownership.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,050

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 19:17 UTC Organon & Co. OGN · Entity 4115 GrantPhantom Stock · Derivative 9,638.554 $20.75 $200,000.00
Disclosure

SEC source: 0001821825-24-000077 · wk-form4_1718133442.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,454.817

Underlying: Common Stock · 9,638.554 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 16:55 UTC COCA COLA CO KO · Entity 2806 GrantPhantom Share Units · Derivative 3,280.3018 $60.97 Strike: $0.00 $200,000.00
Disclosure

SEC source: 0001127602-24-012078 · form4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,143.8912

Underlying: Common Stock, $.25 Par Value · 3,280.3018 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock.

F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2024 compensation, which may include voluntary deferred compensation.

F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4 · balance_after: This number includes phantom share units accrued through April 1, 2024 under the Directors' Plan as a result of crediting phantom dividends.

Read SEC document
December 12, 2023 Filed Dec 13, 2023 21:41 UTC Palo Alto Networks Inc PANW · Entity 1811 GrantCommon Stock 1,308 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058494 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,135

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date.

Read SEC document
June 09, 2023 Filed Jun 13, 2023 20:53 UTC Organon & Co. OGN · Entity 4115 GrantPhantom Stock · Derivative 10,086 $19.83 $200,005.38
Disclosure

SEC source: 0001209191-23-036774 · doc4.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,285

Underlying: Common Stock · 10,086 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on June 16, 2022, September 15, 2022, December 15, 2022 and March 16, 2023.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 18:13 UTC COCA COLA CO KO · Entity 2806 GrantPhantom Share Units · Derivative 3,222.6877 $62.06 Strike: $0.00 $200,000.00
Disclosure

SEC source: 0001127602-23-012090 · form4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,626.9716

Underlying: Common Stock, $.25 Par Value · 3,222.6877 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock.

F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2023 compensation, which may include voluntary deferred compensation.

F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4 · balance_after: This number includes phantom share units accrued through December 15, 2022 under the Directors' Plan as a result of crediting phantom dividends.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 00:04 UTC Palo Alto Networks Inc PANW · Entity 1811 GrantCommon Stock 2,157 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-061313 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,827

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date.

F2 · balance_after: The number of shares beneficially owned reflects the Issuer's 3-for-1 stock split effected September 13, 2022.

Read SEC document
June 10, 2022 Filed Jun 14, 2022 23:37 UTC Organon & Co. OGN · Entity 4115 GrantPhantom Stock · Derivative 5,640 $35.46 $199,994.40
Disclosure

SEC source: 0001104659-22-071138 · tm2218336-6_4seq1.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,638

Underlying: Common Stock · 5,640 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 19:11 UTC COCA COLA CO KO · Entity 2806 GrantPhantom Share Units · Derivative 3,198.9763 $62.52 Strike: $0.00 $200,000.00
Disclosure

SEC source: 0001127602-22-011477 · form4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,284.8982

Underlying: Common Stock, $.25 Par Value · 3,198.9763 shares

Expires not disclosed

F2 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock.

F3 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2022 compensation, which may include voluntary deferred compensation.

F4 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F5 · balance_after: This number includes phantom share units accrued through April 1, 2022 under the Directors' Plan as result of crediting phantom dividends.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 21:25 UTC GoHealth, Inc. GOCO · Entity 22896 GrantDeferred Stock Units · Derivative 5,688 $0.00 $0.00
Disclosure

SEC source: 0001808220-21-000051 · wf-form4_163182748794731.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,831

Underlying: Class A Common Stock · 5,688 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
June 04, 2021 Filed Jun 9, 2021 00:32 UTC Organon & Co. OGN · Entity 4115 GrantPhantom Stock · Derivative 8,772 $36.05 $316,230.60
Disclosure

SEC source: 0000899243-21-022671 · doc4.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,772

Underlying: Common Stock · 8,772 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Consists of (i) a one-time grant of 5,549 phantom units awarded in connection with the separation of Organon & Co. ("Organon") from Merck & Co., Inc. (the "Separation"), which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases.

F2 · derivative.expiration_date: Consists of (i) a one-time grant of 5,549 phantom units awarded in connection with the separation of Organon & Co. ("Organon") from Merck & Co., Inc. (the "Separation"), which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases.

Read SEC document
May 26, 2021 Filed May 28, 2021 20:15 UTC GoHealth, Inc. GOCO · Entity 22896 GrantDeferred Stock Units · Derivative 7,143 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-021104 · doc4.xml · derivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,143

Underlying: Class A Common Stock · 7,143 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer.

F2 · derivative.exercise_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on August 26, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

F2 · derivative.expiration_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on August 26, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

Read SEC document
May 25, 2021 Filed May 26, 2021 20:34 UTC Palo Alto Networks Inc PANW · Entity 1811 GrantCommon Stock 2,890 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035935 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,890

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs shall vest over a three year period, with 1/3 of the shares to vest on May 25, 2022 and the remainder to vest in 1/12 increments on each quarterly anniversary thereafter, subject to the Reporting Person's continued service as of each such date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:24 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 228 $76.48 $17,437.44
Disclosure

SEC source: 0001225208-21-006475 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,063

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:02 UTC COCA COLA CO KO · Entity 2806 GrantPhantom Stock Units · Derivative 3,787.1615 $52.81 Strike: $0.00 $200,000.00
Disclosure

SEC source: 0001127602-21-013153 · form4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,649.0912

Underlying: Common Stock, $.25 Par Value · 3,787.1615 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock.

F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2021 compensation, which may include voluntary deferred compensation.

F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4 · balance_after: This number includes phantom share units accrued through April 1, 2021 under the Directors' Plan as result of crediting phantom dividends.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:38 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 205 $85.10 $17,445.50
Disclosure

SEC source: 0001225208-21-000327 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,747

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 21:10 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 228 $76.68 $17,483.04
Disclosure

SEC source: 0001225208-20-012213 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,461

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:30 UTC GoHealth, Inc. GOCO · Entity 22896 GrantClass A Common Stock 7,143 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-019530 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,143

F1 · shares: Represents a grant of restricted stock units which vest in four equal quarterly installments, with the first such quarterly installment vesting on October 15, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:46 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 240 $72.82 $17,476.80
Disclosure

SEC source: 0001225208-20-009510 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,147

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 11, 2020 Filed May 13, 2020 21:35 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantStock Option (Right to Buy) · Derivative 4,155 $0.00 Strike: $69.83 $0.00
Disclosure

SEC source: 0001225208-20-007606 · doc4.xml · derivative · entry 3

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,155

Underlying: Common Stock · 4,155 shares

Expires 2028-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2020 grant date.

Read SEC document
May 11, 2020 Filed May 13, 2020 21:35 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 2,594 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007606 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,837

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:56 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 260 $67.31 $17,500.60
Disclosure

SEC source: 0001225208-20-006069 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,221

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 19:10 UTC COCA COLA CO KO · Entity 2806 GrantPhantom Stock Units · Derivative 4,680.5523 $42.73 Strike: $0.00 $200,000.00
Disclosure

SEC source: 0001127602-20-013015 · form4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,447.4586

Underlying: Common Stock, $.25 Par Value · 4,680.5523 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock.

F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2020 compensation, which may include voluntary deferred compensation.

F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4 · balance_after: This number includes phantom share units accrued through April 1, 2020 under the Directors' Plan as result of crediting phantom dividends.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionStock Option (Right to Buy) · Derivative 3,802 $0.00 Strike: $71.65 $0.00
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 12

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,901

Underlying: Common Stock · 3,802 shares

Expires 2023-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F8 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionStock Option (Right to Buy) · Derivative 2,109 $0.00 Strike: $62.04 $0.00
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 11

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,220

Underlying: Common Stock · 2,109 shares

Expires 2024-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F7 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionStock Option (Right to Buy) · Derivative 5,357 $0.00 Strike: $67.19 $0.00
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 10

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,357 shares

Expires 2020-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F6 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 12, 2014 grant date.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionStock Option (Right to Buy) · Derivative 5,583 $0.00 Strike: $67.83 $0.00
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 9

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,583 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F5 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May, 11, 2015 grant date.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionStock Option (Right to Buy) · Derivative 5,389 $0.00 Strike: $71.76 $0.00
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 8

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,389 shares

Expires 2022-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 SaleCommon Stock 22,240 $76.08 $1,692,128.18
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 6

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,890

F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.

F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $76.03 to $76.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionCommon Stock 2,109 $62.04 $130,842.36
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 5

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionCommon Stock 3,802 $71.65 $272,413.30
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 4

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,021

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionCommon Stock 5,357 $67.19 $359,936.83
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 3

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionCommon Stock 5,389 $71.76 $386,714.64
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 21:53 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionCommon Stock 5,583 $67.83 $378,694.89
Disclosure

SEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 22:25 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 256 $68.25 $17,472.00
Disclosure

SEC source: 0001225208-20-000553 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,890

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 21:55 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 241 $72.44 $17,458.04
Disclosure

SEC source: 0001225208-19-013193 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,562

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 21:05 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 240 $72.67 $17,440.80
Disclosure

SEC source: 0001225208-19-010058 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,389

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 13, 2019 Filed May 15, 2019 20:33 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantStock Option (Right to Buy) · Derivative 4,170 $0.00 Strike: $71.56 $0.00
Disclosure

SEC source: 0001225208-19-008058 · doc4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,170

Underlying: Common Stock · 4,170 shares

Expires 2027-05-13

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date.

Read SEC document
May 13, 2019 Filed May 15, 2019 20:33 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 2,515 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008058 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,084

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
May 03, 2019 Filed May 7, 2019 22:31 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionStock Option (Right to Buy) · Derivative 5,780 $0.00 Strike: $60.45 $0.00
Disclosure

SEC source: 0001223203-19-000021 · primary_doc.xml · derivative · entry 3

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,780 shares

Expires 2019-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options granted under the issuer's incentive compensation plan.

F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2013 grant date.

Read SEC document
May 03, 2019 Filed May 7, 2019 22:31 UTC COLGATE PALMOLIVE CO CL · Entity 2972 SaleCommon Stock 5,780 $71.95 $415,846.15
Disclosure

SEC source: 0001223203-19-000021 · primary_doc.xml · nonDerivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.

F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.89 to $72.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 03, 2019 Filed May 7, 2019 22:31 UTC COLGATE PALMOLIVE CO CL · Entity 2972 Exercise / conversionCommon Stock 5,780 $60.45 $349,401.00
Disclosure

SEC source: 0001223203-19-000021 · primary_doc.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,349

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options granted under the issuer's incentive compensation plan.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:51 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 264 $66.22 $17,482.08
Disclosure

SEC source: 0001225208-19-006348 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:47 UTC COCA COLA CO KO · Entity 2806 GrantPhantom Stock Units · Derivative 4,266.2116 $46.88 Strike: $0.00 $200,000.00
Disclosure

SEC source: 0001127602-19-014650 · form4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,567.0822

Underlying: Common Stock, $.25 Par Value · 4,266.2116 shares

Expires not disclosed

F2 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock.

F3 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2013 (the "Directors' Plan") for 2019 compensation, which may include voluntary deferred compensation.

F4 · derivative.exercise_date: The phantom share units credited under The Coca-Cola Company Directors' Plan effective January 1, 2013 (the "Directors' Plan") are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F4 · derivative.expiration_date: The phantom share units credited under The Coca-Cola Company Directors' Plan effective January 1, 2013 (the "Directors' Plan") are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.

F5 · balance_after: This number includes phantom share units accrued through April 1, 2019 under the Directors' Plan as result of crediting phantom dividends.

Read SEC document
January 02, 2019 Filed Jan 3, 2019 22:08 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 281 $62.24 $17,489.44
Disclosure

SEC source: 0001225208-19-000454 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,254

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:27 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 259 $67.53 $17,490.27
Disclosure

SEC source: 0001225208-18-014327 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,922

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 21:20 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantCommon Stock 274 $63.76 $17,470.24
Disclosure

SEC source: 0001225208-18-011356 · doc4.xml · nonDerivative · entry 1

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,616

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 14, 2018 Filed May 16, 2018 20:42 UTC COLGATE PALMOLIVE CO CL · Entity 2972 GrantStock Option (Right to Buy) · Derivative 6,329 $0.00 Strike: $62.04 $0.00
Disclosure

SEC source: 0001225208-18-009467 · doc4.xml · derivative · entry 2

Gayle Helene D · CIK 0001487047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,329

Underlying: Common Stock · 6,329 shares

Expires 2024-05-14

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 14, 2018 grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.